A listing of human tumor antigens recognized by T cells: March 2004 update Luisa NovellinoChiara CastelliGiorgio Parmiani Review 07 August 2004 Pages: 187 - 207
Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma Peter HerseyScott W. MenziesHeather Johnson Original Article 21 September 2004 Pages: 208 - 218
Spontaneous T-cell responses against peptides derived from the Taxol resistance–associated gene-3 (TRAG-3) protein in cancer patients Anders MeierSine RekerPer thor Straten Original Article 02 October 2004 Pages: 219 - 228
NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin Ming Yu CaoYoon LeeAiping H. Young Original Article 17 September 2004 Pages: 229 - 242
Peptide immunisation of HLA-DR–transgenic mice permits the identification of a novel HLA-DRβ1*0101– and HLA-DRβ1*0401–restricted epitope from p53 José Manuel RojasStephanie E. B. McArdleRobert C. Rees Original Article 21 September 2004 Pages: 243 - 253
Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer Ramesh K. RamanathanKenneth M. LeeOlivera J. Finn Original Article 14 September 2004 Pages: 254 - 264
Preoperative mannan-binding lectin pathway and prognosis in colorectal cancer Henriette YttingIb Jarle ChristensenHans Jørgen Nielsen Original Article 21 September 2004 Pages: 265 - 272
Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines Elena CitteraChiara OnofriJosée Golay Original Article 23 September 2004 Pages: 273 - 286
Bridging the innate and adaptive immune responses against cancer: 95th AACR meeting 2004 Olivera J. Finn Meeting Report 29 October 2004 Pages: 287 - 289
Immunotherapy at the American Association for Cancer Research 95th annual meeting: a personal impression Barbara-ann Guinn Meeting Report 14 September 2004 Pages: 290 - 295
